| Active Substance/INN | Bortezomib |
|---|---|
| Dosage | 2.5 mg/ml |
| Pharmaceutical Form | Injectable solution |
| Product Type |
Bortezomib EVER Pharma (Bortezomib)
Pharmacotherapeutic Group: Oncology
Biojam Area: Biojam Pharma Portugal
Related products
Vascular
Parkinson's disease
Parkinson's disease
Intensive Care, Emergency Medicine, Internal Medicine
Vascular
Intensive Care, Emergency Medicine, Internal Medicine





